Aggressive prostate cancer incidence in new Zealand-"united we fall, divided we stand"
Vaidyanathan, V.; Karunasinghe, N.; Krishnamurthy, V.; Kao, C.H.-J.; Naidu, V.; Pallati, R.; Wang, A.; Tran, K.; Kallingappa, P.; Jabed, A.; Shahid, S.M.; Masters, J.; Wall, C.; Narayanan, A.; Ferguson, L.R.
New Zealand Medical Journal 130(1466): 96-99
2017
ISSN/ISBN: 1175-8716 PMID: 29197908 Document Number: 694671
Prostate cancer is an important health burden to the healthcare system of any country. However, with the current prostate-specific antigen biomarker having low predictive value even for diagnostic purposes, the challenge is still open to tackle this chronic disease. There have been a number of studies which have indicated and encouraged a multi-directional approach to combat this disease. We have been carrying out a multi-directional approach in order to identify certain New Zealand-specific factors which may be drivers for this cancer and its aggressive forms. These will be explained in further detail in this research letter.